Status:
COMPLETED
SchlaHF-XT-Register. Sleep Disordered Breathing in Heart Failure Register
Lead Sponsor:
ResMed
Conditions:
Heart Failure (HF)
Eligibility:
All Genders
18+ years
Brief Summary
The SchlaHF XT Registry is a longitudinal study of patients with heart failure (HF). The study aims to understand the importance of diagnosis and treatment of sleep disordered breathing (SDB) on HF wi...
Eligibility Criteria
Inclusion
- diagnose chronic heart failure, at least 3 months prior to diagnosis
- Age 18 years
- Signed informed consent
Exclusion
- Existing Positive Airway Pressure (PAP) therapy or long-term oxygen therapy
- Lack of capacity to consent
- minors
- persons who are housed on judicial or administrative order in an institution
- pregnant and lactating women
Key Trial Info
Start Date :
May 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2018
Estimated Enrollment :
4749 Patients enrolled
Trial Details
Trial ID
NCT02301689
Start Date
May 1 2014
End Date
June 1 2018
Last Update
April 9 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Heart and Diabetes Centre
Bad Oeynhausen, North Rhine-Westphalia, Germany, 32545